期刊
BIOENGINEERING & TRANSLATIONAL MEDICINE
卷 8, 期 3, 页码 -出版社
WILEY
DOI: 10.1002/btm2.10471
关键词
glycolysis; immunometabolism; macrophage; mesenchymal stromal; stem cells; myocardial infarction; patch
This study found that the administration of an inhibitor of glycolysis, 2-DG, blocked the hyperinflammatory response within the ischemic myocardium and extended effective retention of transplanted MSCs. A novel chitosan/gelatin-based 2-DG patch was developed to directly facilitate MSC-mediated cardiac healing in the infarcted region.
Mesenchymal stromal/stem cells (MSCs) have emerged as a promising approach against myocardial infarction. Due to hostile hyperinflammation, however, poor retention of transplanted cells seriously impedes their clinical applications. Proinflammatory M1 macrophages, which rely on glycolysis as their main energy source, aggravate hyperinflammatory response and cardiac injury in ischemic region. Here, we showed that the administration of an inhibitor of glycolysis, 2-deoxy-d-glucose (2-DG), blocked the hyperinflammatory response within the ischemic myocardium and subsequently extended effective retention of transplanted MSCs. Mechanistically, 2-DG blocked the proinflammatory polarization of macrophages and suppressed the production of inflammatory cytokines. Selective macrophage depletion abrogated this curative effect. Finally, to avoid potential organ toxicity caused by systemic inhibition of glycolysis, we developed a novel chitosan/gelatin-based 2-DG patch that directly adhered to the infarcted region and facilitated MSC-mediated cardiac healing with undetectable side effects. This study pioneered the application of an immunometabolic patch in MSC-based therapy and provided insights into the therapeutic mechanism and advantages of this innovative biomaterial.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据